相关实验视频
Updated: Jul 4, 2025

09:42
A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model
Published on: June 4, 2021
2.7K
一个患有性夜间血红蛋白尿症的患者的多位瘤
Lennart Beckmann1, Tobias D Faizy2, Fabian Flottmann2
1Zentrum für Onkologie, II. Medizinische Klinik und Poliklinik, Universitätsklinikum Eppendorf, Hamburg, Germany.
Hamostaseologie
|February 9, 2024
概括
性夜间血红蛋白尿 (PNH) 是一种罕见的骨髓疾病. 它是由于基因突变导致补体调节者的损失造成的,导致血液溶解,细胞衰减和高血栓形成风险.
科学领域:
- 血液学 血液学 血液学
- 遗传学 是一个遗传学.
- 免疫学 免疫学 免疫学
背景情况:
- 性夜间血红蛋白尿 (PNH) 是一种极其罕见的骨髓疾病.
- 它是由酸氨基类A基因中获得的突变引起的.
- 这导致补充调节器CD55和CD59的部分或全部丧失.
研究的目的:
- 要总结PNH的关键特征.
- 为了突出与PNH相关的并发症.
主要方法:
- 对现有文献和历史患者队列的审查.
- 分析遗传突变及其对补体调节的影响.
主要成果:
- PNH的特征是补充介导的血液溶解和细胞衰减.
- 静脉和动脉血栓是常见的,发生在高达44%的患者在历史的队列.
- 血栓通常发生在多个和/或不寻常的部位.
结论:
- 除了血液溶解和细胞衰减之外,PNH存在巨大的血栓形成风险.
- 了解遗传基础和并发症对于患者管理至关重要.
相关概念视频
Disorders of Hemostasis
911
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
911
Anticoagulant Drugs: Low-Molecular-Weight Heparins
698
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
698

